The burden of gynecological cancer management in Northern Nigeria


Background: Carcinoma of the Cervix is one of the gynecologic cancers. Gynecological cancer is a scourge in the developing nations because of the burden of cervical cancer. Carcinoma of the cervix is the leading cause of cancer death in women. The costs of treatment of cancers generally are very high and this has made care very difficult in the developing nations. The question therefore is who bears the cost and whose responsibilities? Aims and Objective: To study the economic burden of cancers on the patient, and how they source for these funds. To determine how the lack of funds or otherwise has affected their care. To assess their perception of who should bear the cost of this care. Methodology: It is a prospective study of all consecutive patients that attended the Gynecologic clinic of our unit between 2nd January 2010 and 30th June 2010. Data were analyzed using Excel statistical package. Result: A total of 93 patients were interviewed. A majority of 70 (76%) of the patients had Carcinoma of the cervix. The mean age of there husbands was 58 years. Most of them were either farmers (21%) or retired civil/public servants (15%) and earn between 700 - 1700 dollars per year. A large group of the patients were full time House wives (48%), while Petty trading and farming account for 13.3% each. The women earn less than 500 dollars per year. Only 50% received assistance, from family members (35.8%) or relatives (29.6%). More than 50% of them have spent between 1000 - 3000 dollars for their health bills. It was sad to note that 40% of them have no hope of help/assistance from anywhere. A majority of 83.3% believe that the government should come to their aids. Conclusion: In the developing nations, poverty still remains major problem, where people still earn less than a dollar per day. In essence prevention is paramount; otherwise most of our women who escaped maternal mortality may end up being a victim of cancer death.

Share and Cite:

Oguntayo, A. , Zayyan, M. , Akpar, M. , Kolawole, A. and Adewuyi, S. (2013) The burden of gynecological cancer management in Northern Nigeria. Open Journal of Obstetrics and Gynecology, 3, 634-638. doi: 10.4236/ojog.2013.38115.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Merletti, F., Galassi, C. and Spadea, T. (2011) The socioeconomic determinants of cancer. Environmental Health 2011, 10, S7. 10.1186/1476-069X-10-S1-S7
[2] Ferlay, J., Shin, H.R., Bray, F., Forman, D., Mathers, C.D. and Parkin, D. (2008) GLOBO-CAN 2008, cancer incidence and mortality worldwide: IARC cancer-base No.10. International Agency for Research on Cancer, Lyon.
[3] Quinn, P., (2011) Cancer and your environment in cancer in illinois. cancer/factsheets/cancer.htm
[4] Mohammed, A., Ahmed, S.A., Oluwole, O.P. and Avidime, S. (2006) Malignant tumours of the female genital tract in Zaria, Nigeria: Analysis of 513 cases. Annals of African Medicine, 5, 93-96.
[5] Oguntayo1, O.A., Zayyan1, M., Kolawole, A.O.D., Adewuyi1, S.A., Ismail1, H. and Koledade1, K. (2011) Cancer of the cervix in Zaria Northern Nigeria. Ecancermedicalscience, 5, 219.
[6] Organization for Economic Co-operation and Development, Development Assistance Committee (DAC). (2002) Online database and data on GDP from World Bank, Paris.
[7] Human Development Report 2006, United Nations Development Programme; World Bank, 2002. World Development Indicators 2002. CD-ROM. Washington, DC.
[8] Adebola, S.A. (2008) An overview of developments in Health Care Administration in Nigeria (1960-2005). In: Saliu, H.A., et al., Eds., Perspective on nation-building and development in Nigeria, Concept Publications Limited, Lagos.
[9] Ugbolue, H. and Olabi, O. (1997) Begging for a living. The News Magazine, 9.
[10] World Health Organization (WHO). (2001) Correspondence on access to essential drugs. Department of Essential Drugs and Medecines Policy. Geneva.
[11] Labor force; female (% of total Labor force) in Nigeria in trading economic of the World Bank data compiled 2010 and published 2012.
[12] Jonas, A. and de Souza, M.D. (2012) The cost of cancer care: There is more than one elephant in the room. Oncology, 26, 926-928.
[13] Rettenmaier, A.J. (2012) Healthcare financing and the cost of cancer care. Oncology, 26, 924; 926.
[14] Cancer trends progress report 2011/2012 update. (2012) National Cancer Institute, U.S National Institute of Health.
[15] Metiboba, S. (2011) Nigeria’s national health insurance scheme: The need for beneficiary participation. Research Journal of International Studies, 22, 51-56. international_studies.htm
[16] Chemo, F.X. (2009) A product of precision therapeutics. Precision Therapeutics Inc., Pittsburgh.
[17] Tangka, F.K., Trogdon, J.G., Richardson, L.C., Howard, D., Sabatino, S.A. and Finkelstein, E.A. (2010) Cancer treatment cost in the United States: Has the burden shifted over time? Cancer, 116, 3577-3484.

Copyright © 2022 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.